Rankings
▼
Calendar
PHIO Q1 2021 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena
PHIO
Phio Pharmaceuticals Corp.
$13M
Q1 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$2M
Operating Income
-$4M
Net Income
-$3M
EPS (Diluted)
$-34.49
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$67,000
Balance Sheet
Total Assets
$34M
Total Liabilities
$2M
Stockholders' Equity
$31M
Cash & Equivalents
$33M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$2M
-$45,000
-5297.8%
Operating Income
-$4M
-$2M
-54.4%
Net Income
-$3M
-$2M
-44.9%
← FY 2021
All Quarters
Q2 2021 →